Stock listing
EMD Stock Price, News, Filings & Events — Emyria Ltd
Selected listing: EMD · ASX · AUD · AU
This page tracks Emyria Ltd's EMD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EMD:ASX. EMD:ASX is the stock-level entry point for investors researching Emyria Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Emyria Ltd (ticker: EMD) is a public company based in Australia with a market capitalization of approximately AUD 25.3 million. The company is focused on developing innovative treatments for mental health and other conditions. Emyria aims to leverage its expertise in clinical research to bring new therapies to market.

- Ticker
- EMD:ASX
- Asset type
- Stock
- Market cap
- $26.9M
- Sector
- Technology Services
- Industry
- Packaged Software
- Exchange
- ASX
- Currency
- AUD
Emyria Ltd EMD:ASX stock context
This page tracks Emyria Ltd's EMD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EMD:ASX. EMD:ASX is the stock-level entry point for investors researching Emyria Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Emyria Ltd (ticker: EMD) is a public company based in Australia with a market capitalization of approximately AUD 25.3 million. The company is focused on developing innovative treatments for mental health and other conditions. Emyria aims to leverage its expertise in clinical research to bring new therapies to market.
Latest news from Emyria Ltd
Research Emyria Ltd
Emyria Ltd investor report
Review AI stock analysis and investor report context for EMD:ASX.
Emyria Ltd company profile
View the public company page for Emyria Ltd on 6ix.
Emyria Ltd news
Read company news and market updates connected to Emyria Ltd.
Emyria Ltd investor events
Find investor webinars, events, and replay context for Emyria Ltd.